Novartis India Ltd. Said its board recommended a dividend of 200 percent or Rs.10.00 per equity share of Rs.5 each for the fiscal year 012.
dividend, if approved by the shareholders in the AGM to be held on July 25, shall be paid on or after July 30, 2012.
The company posted fourth-quarter stand-alone net profit of Rs.32.91 crore, down by three from the Rs.34.08 crore for the quarter ended March 31 last year. Total income from operations, including other operating income, rose by 12 percent to Rs.204.48 crore from the Rs.182.73 crore in the year-ago quarter.
During the quarter, income from 'Pharmaceutical' segment stood at Rs.138.85 crore, while that from 'Generics' was Rs.13.98 crore. Income from 'OTC' segment amounted to Rs.29.29 crore and that from 'Animal Health' totaled Rs.22.36 crore.
For the fiscal year, its stand-alone net profit stood at Rs.152.02 crore, compared with Rs.146.67 crore in 2011, reflecting a four percent growth. Total income from operations, including other operating income, amounted to Rs.844.29 crore, up by 12 percent from the Rs.751.21 crore a year-ago.
The results for the year were impacted due to unprecedented downward spiral in the value of the rupee.
At the BSE, Novartis India shares are currently trading at Rs.715.15, up 0.01 percent from the previous close.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.